TEVA · Categories · Downgrades
TEVA - Analyst downgrades
Teva Pharmaceutical Industries Limited (TEVA) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for TEVA
- Teva Pharma downgraded by Jefferies with a new price targetJefferies downgraded Teva Pharma from Buy to Hold and set a new price target of $12.00 from $10.00 previously
- Teva Pharma downgraded by JP Morgan with a new price targetJP Morgan downgraded Teva Pharma from Neutral to Underweight and set a new price target of $10.00 from $11.00 previously
- Teva Pharma downgraded by UBSUBS downgraded Teva Pharma from Neutral to Sell
- Teva Pharma downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Teva Pharma from Neutral to Underweight and set a new price target of $7.00 from $11.00 previously
- Teva Pharma downgraded by ArgusArgus downgraded Teva Pharma from Buy to Hold
- Teva Pharma downgraded by Raymond JamesRaymond James downgraded Teva Pharma from Outperform to Mkt Perform
- Teva Pharma downgraded by UBS with a new price targetUBS downgraded Teva Pharma from Buy to Neutral and set a new price target of $11.00 from $15.00 previously